QuidelOrtho Looks Mispriced If 2026's FCF Turnaround Materializes [Seeking Alpha]
QuidelOrtho Corporation (QDEL)
Last quidelortho corporation earnings: 2/12 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.quidel.com
Company Research
Source: Seeking Alpha
However, the rest of their portfolio is actually growing. Labs is the primary revenue engine, contributing 55% of sales in 2025. Likewise, Immunohematology also expanded and supports a healthier underlying mix. Its IVD portfolio spans central labs, blood banking, point of care, and molecular testing, making it relatively diversified. As such, my bull case rests on their turnaround execution, which could unlock a positive stock re-rating if it succeeds. dimid_86/iStock via Getty Images QuidelOrtho Corporation ( QDEL ) is a global provider of diagnostic solutions. They develop products for Labs, Transfusion Medicine (including Immunohematology and Donor Screening), Point of Care, and Molecular Diagnostics. QDEL's 2025 total revenues fell from $2.78 billion to $2.73 billion. However, I believe the business
Show less
Read more
Impact Snapshot
Event Time:
QDEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QDEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QDEL alerts
High impacting QuidelOrtho Corporation news events
Weekly update
A roundup of the hottest topics
QDEL
News
- QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics [TheStreet.com]TheStreet.com
- QuidelOrtho Corporation Completes Acquisition of LEX DiagnosticsPR Newswire
- QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance [TheStreet.com]TheStreet.com
- QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 GuidancePR Newswire
- QuidelOrtho (QDEL) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=QDEL&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" to "hMarketBeat
QDEL
Earnings
- 2/11/26 - Beat
QDEL
Sec Filings
- 4/15/26 - Form 8-K
- 4/8/26 - Form SCHEDULE
- 3/31/26 - Form 3
- QDEL's page on the SEC website